Michael has held the position of president and CEO of Daxor Corporation since 2017. Prior to this, he served as a member of the board of directors before joining Daxor’s executive team in December of 2014. Michael has over 25 years of experience on Wall Street and in the medical field. He served as a managing director and portfolio manager for Morgan Stanley for six years and a managing director of Millennium Partners for eight years in addition to leading his own hedge fund, Aristarc Capital, from 2009 to 2013. Michael began his career at D.E. Shaw & Co. in New York, where he worked with Jeffery Bezos prior to Bezos’s founding of Amazon. Michael earned his bachelor’s degree in pre-med studies at Columbia College, Columbia University in 1991. Michael’s interests include photography and travel.

Bob is a certified public accountant and gained his public accounting experience at Price Waterhouse in New York the predecessor firm to pwc. Bob graduated from Villanova University’s School of Business with a degree in Business Administration and has an MBA from St. John’s University. He has a diverse background with more than 30 years of financial experience in manufacturing, advertising and financial services. Immediately prior to joining Daxor Corporation, Bob was the CFO of a moving and storage company most recently at Sher-Del Transfer and Relocation Services. Bob was the CFO for 7 years at Asta Funding, Inc., a publicly traded diversified financial services company that trades on the Nasdaq. He enjoys running, cycling and has hiked across the Grand Canyon.

Jonathan is the co-inventor of the BVA-100 and associated patents. He is responsible for algorithmic design, statistical analysis and for patent applications for the next generation blood volume analyzer and its utility across diverse surgical and medical conditions. Jonathan has developed black-box trading and analytical systems for Wall Street firms such as Morgan Stanley, Millennium Partners, and Shearson Lehman and served in the past as chief quantitative officer for Aristarc Capital and as the CEO of Outseeker, a data-driven technology startup. Jonathan has an A.B. in physics summa cum laude from Harvard. He enjoys art and rock climbing.

John is a board certified cardiologist. He completed his training in Adult Cardiovascular Diseases at the Texas Heart Institute and Pediatric Cardiology at Texas Children’s Hospital both at the Baylor College of Medicine in Houston, Texas. He received an MPH from the University of Kentucky and an MBA from the Wharton School of Business at the University of Pennsylvania. John has published over 300 peer-reviewed manuscripts focused on heart failure, cardiomyopathies, heritable disease, genetics, and artificial intelligence, and is an Editor of two leading cardiovascular textbooks. He has been an academic cardiologist for over two decades and remains actively involved in clinical research and physician leadership roles at the local, national, and international levels. John’s interests include outdoor sports and travel.

Kathy has held leadership roles in global marketing, business development, and sales with major international IVD medical device companies including Abbott, HemoCue and Ortho Clinical Diagnostics. In addition to her business experience, Kathy is an American Society of Clinical Pathology-certified Medical Technologist with clinical lab experience in hematology and microbiology. She holds a bachelor degree in biology from University of Delaware and a bachelor of science degree in medical technology from Thomas Jefferson University. Kathy’s interests include water sports and travel.

Linda has over 30 years of experience in product development and commercialization in the medical device industry. She has held senior leadership roles with major medical device companies including OsteoCentric Technologies and Integra LifeSciences where she oversaw multiple product launches through the entire product development process including hardware design, testing, regulatory clearance, and launch. She earned her Bachelor of Science degree in biomedical engineering from the University of Iowa and is an inventor on a U.S. patent for a bone plate system for repair of proximal humeral fracture. Linda’s interests include yoga and travel.

Noa is a trained cellular and molecular biologist with research experience at the Weizmann Institute of Science and Weill Cornell Medical School. She has over 10 years of experience in assisting life science organizations secure non-dilutive funding from U.S. federal agencies and private foundations. Noa has developed a robust portfolio of grants and contracts to support the development and validation of Daxor technologies. She holds a Bachelor and Master of Science in Cell and Molecular Biology and Genetic Engineering, as well as a Master of Business Administration from the University of Tel Aviv. Noa’s interests include technology, languages, and bioethics.

Annette is a high-performance commercial leader with a 25-year legacy of driving growth in med-tech and diagnostics. Honorably discharged as a Captain in the U.S. Air Force Nurse Corps, she leverages her clinical background as a registered nurse to bridge the gap between complex technology and bedside application. Annette has held pivotal leadership roles at GenePath Dx, Pathnostics, and The Binding Site, where she excelled at scaling sales efficiency and launching disruptive care pathways. She holds a Master of Science in Administration from Central Michigan University and a Bachelor of Science in Nursing from Georgetown University. Annette enjoys traveling and spending time outdoors with family.

Daniel brings an extensive background in radiochemistry, laboratory automation, and product development to the Daxor team. After earning his Ph.D. in Inorganic Chemistry from Emory University and completing a postdoctoral fellowship at Oak Ridge National Laboratory, he spent over a decade at Best ABT. Rising to Director of R&D, he advanced PET radiopharmaceutical production and automated quality control. Most recently, he drove R&D for radioisotope power sources at Direct Kinetics Solutions. As a dedicated safety leader, Daniel has extensive experience managing cGMP and ISO 13485 compliance and serving as a Radiation Safety Officer (RSO). Outside the lab, Daniel enjoys "chemistry you can taste" through cooking and home brewing.